Hans van Houte

Insider Reports History

Entity
Individual
Location
C/O Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco, CA
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Hans van Houte
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hans van Houte:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 37.5K $911K $24.31 Oct 30, 2024 Direct
Nurix Therapeutics, Inc. Chief Financial Officer Common Stock 33.7K $819K $24.28 Nov 1, 2024 Direct
Nurix Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 150K Feb 13, 2024 Direct

Insider Reports Filed by Hans van Houte

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRIX Nurix Therapeutics, Inc. Nov 1, 2024 1 -$86.1K 4 Nov 1, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Oct 30, 2024 7 -$57.6K 4 Oct 30, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Aug 26, 2024 1 -$504K 4 Aug 26, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Aug 1, 2024 2 -$74.6K 4 Aug 1, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Jul 30, 2024 7 -$51.5K 4 Jul 30, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Jun 20, 2024 1 -$400K 4 Jun 20, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. May 2, 2024 1 -$44.9K 4 May 2, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Apr 30, 2024 5 -$16.7K 4 Apr 30, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Feb 16, 2024 1 -$68.2K 4 Feb 16, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Feb 13, 2024 2 $0 4 Feb 15, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Jan 30, 2024 5 -$13.4K 4 Jan 30, 2024 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Dec 20, 2023 1 -$35.4K 4 Dec 21, 2023 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Dec 19, 2023 1 -$109K 4 Dec 20, 2023 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Oct 30, 2023 5 -$5.61K 4 Nov 1, 2023 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Jul 30, 2023 5 -$12K 4 Aug 1, 2023 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Apr 30, 2023 3 -$7.12K 4 May 2, 2023 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Feb 14, 2023 2 $0 4 Feb 15, 2023 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Jan 30, 2023 3 -$10.9K 4 Feb 1, 2023 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Oct 30, 2022 3 -$9.52K 4 Nov 1, 2022 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Aug 9, 2022 1 $0 4 Aug 10, 2022 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Jul 30, 2022 3 -$11.8K 4 Aug 2, 2022 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. May 31, 2022 2 $57.4K 4 Jun 1, 2022 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Apr 30, 2022 3 -$8.19K 4 May 3, 2022 Chief Financial Officer
NRIX Nurix Therapeutics, Inc. Jan 19, 2022 2 $0 4 Jan 21, 2022 Chief Financial Officer